1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > MicroVention, Inc. - Product Pipeline Analysis, 2015 Update

MicroVention, Inc. - Product Pipeline Analysis, 2015 Update

  • September 2015
  • -
  • GlobalData
  • -
  • 25 pages

Summary

Table of Contents

Search Inside

Summary

MicroVention, Inc. (MicroVention), a subsidiary of Terumo Corporation is a medical device company that develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. The company’s products include platinum coils, hydrogel coils, delivery and detachment system, access products and intraluminal devices. It offers platinum coil products such as complex coils, platinum coils, helical platinum coils, finishing coils and 3D complex coil. MicroVention provides neuro-interventional products that include access products, intraluminal stents, occlusion balloons, polymer coils and flow diverters. The company markets its products through a network of distributors in the US, the UK, Canada, France and Germany. MicroVention is headquartered in Tustin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MicroVention, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Autism - Pipeline Review, H1 2017

Autism - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Autism - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Autism – Pipeline Review, H1 2017, provides an overview of the Autism (Central ...

Cerebral Palsy - Pipeline Review, H1 2017

Cerebral Palsy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Cerebral Palsy - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy – Pipeline Review, H1 2017, provides an overview of ...

Trigeminal Neuralgia - Pipeline Review, H1 2017

Trigeminal Neuralgia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Trigeminal Neuralgia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2017, provides an ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.